KLS-13019 is a Cannabidiol-Derived Neuroprotective Agent with Improved Potency, Safety, and Permeability. (EC50=40nM; T1=7500). KLS-13019 was 50-fold more potent and >400-fold safer than cannabidiol and exhibited an in vitro profile consistent with improved orally bioavailable bioavailability. KLS-13019 was only toxic at 300 μM giving it a therapeutic index of 7500. References:

纯度：≥98%

CAS：1801243-39-9